This invention provides a fully continuous preparation method for
probucol active pharmaceutical ingredient intermediates, belonging to the field of
organic synthesis technology. The method includes the following steps: a
mixed solution of 2,6-di-tert-butylphenol and elemental
iodine, and a
sulfur monochloride solution are continuously passed into a microchannel reactor for a
condensation reaction, followed by cooling of the reaction solution; then, the solution is continuously passed into a fixed-
bed reactor for hydrogenation under the
catalysis of
sulfur-modified Ni-Co / Al2O3. This invention combines a microchannel
continuous flow reactor and a fixed-
bed reactor for the continuous synthesis of
probucol active pharmaceutical ingredient intermediates. The process steps and operations are simple, reducing intermediate purification steps and shortening the
processing time; the
solvent has
low toxicity, making the method green, safe, and
environmentally friendly; the raw materials are inexpensive and readily available, the
reaction conditions are mild, and the target product has high yield and purity, resulting in good product quality; the use of the microchannel
continuous flow reactor improves the
mass and
heat transfer of materials, reduces the amount of excipients, and further reduces production costs.